πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 67 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11918627

Dosage regimen for inhaled vasoactive intestinal polypeptide

CENTURION ÌLAΓ‡ SANAYI VE TICARET ANONIM SIRKETI Β· Granted Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11903994

Dosing regimens

Apellis Pharmaceuticals, Inc. Β· Granted Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11890272

Non-sedating dexmedetomidine treatment regimens

BioXcel Therapeutics, Inc. Β· Granted Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11844841

Dosing regimens and related compositions and methods

Apellis Pharmaceuticals, Inc. Β· Granted Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11839611

Buprenorphine dosing regimens

Indivior UK Limited Β· Granted Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11806334

Non-sedating dexmedetomidine treatment regimens

BioXcel Therapeutics, Inc. Β· Granted Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11744828

Regimens of tafenoquine for prevention of malaria in malaria-naΓ―ve subjects

The Government of the United States, as represented by the Secretary of the Army Β· Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11749394

Method and apparatus for providing a pharmacokinetic drug dosing regimen

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11732037

Weight loss regimen

Boards of Regents, The University of Texas System Β· Granted Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11670409

Method and apparatus for providing a pharmacokinetic drug dosing regiment

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11590154

Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for t

RedHill Biopharma Ltd. Β· Granted Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11559567

Dosage regimen for pegylated interferon

PHARMAESSENTIA CORPORATION Β· Granted Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11419869

Dosage forms and regimens for amino acid compounds

Pliant Therapeutics, Inc. Β· Granted Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11129810

Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary d

MEREO BIOPHARMA 1 LIMITED Β· Granted Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11040107

Dosing regimens and related compositions and methods

Apellis Pharmaceuticals, Inc. Β· Granted Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11000520

Buprenorphine dosing regimens

Indivior UK Limited Β· Granted Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10888558

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

The Government of the United States, as represented by the Secretary of the Army Β· Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10617674

Dosage regimen for the treatment of acute exacerbations of inflammatory conditions

MEREO BIOPHARMA 1 LIMITED Β· Granted Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10603306

Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary d

MEREO BIOPHARMA 1 LIMITED Β· Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10428157

Dosing regimens for use with PCSK9 inhibitors

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10342791

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10335460

IL-15 and IL-15RΞ± heterodimer dose escalation regimens for treating conditions

THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9498468

Rhinitis treatment regimens

Pharmaceutical Design, LLC Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9314486

Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells

Montefiore Medical Center Β· Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted